Effectiveness of Different Types of Training in Older Adults With Sarcopenic Obesity

NCT06895122 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-03-30

No results posted yet for this study

Summary

This study is a randomized, parallel-group, double-blind clinical trial. The primary aim is to assess the effectiveness of power-based resistance training, multimodal exercise incorporating non-specific movements, and a control group in improving functionality and body composition in women over 65 years old with pre-sarcopenia. The intervention will take place over 30 weeks, with three training sessions per week in both experimental groups. Assessments will be conducted at two time points: before and after the intervention. Evaluated parameters will include functionality (Timed Up \& Go test (TUG), chair stand test, handgrip strength, and Short Physical Performance Battery (SPPB)) and body composition (body fat percentage, skeletal muscle index (SMI), appendicular skeletal muscle mass (ASM), waist circumference, waist-to-hip ratio, body weight, and body mass index (BMI)).

Conditions

  • Sarcopenic Obesity
  • Obesity and Overweight
  • Sarcopenia

Interventions

PROCEDURE

High resistance training

Participants will perform the exercises at high speed, emphasizing explosive movements to maximize muscle power development.

PROCEDURE

Multicomponent Training

Various exercise modalities are integrated, including aerobic training, mobility, strength, balance, and coordination exercises.

Sponsors & Collaborators

  • University of Salamanca

    lead OTHER

Principal Investigators

  • Roberto Méndez Sánchez, PhD · University of Salamanca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06895122 on ClinicalTrials.gov